#ESHMDS2022 GOING VIRTUAL! REGISTER NOW!

 

8th Translational Research Conference

MYELODYSPLASTIC SYNDROMES

 

GOING VIRTUAL! E-Conference

April 7-10, 2022

#ESHMDS2022

FREE REGISTRATION

   

---

In view of continuing COVID-19 related challenges and uncertainties,
the ESH 8th Translational Research Conference
MYELODYSPLASTIC SYNDROMES
will be held as a VIRTUAL EVENT.

The safety of our speakers and attendees comes first.
We successfully transformed our last 14 conferences into E-Conferences
and will place you in the best dispositions to enjoy the presentations and discussions.

The E-Conference will take place from
Thursday, April 7th to Sunday, April 10th, 2022

REGISTRATION IS OFFERED FOR FREE
as a gesture of solidarity during these difficult times.
Registration is opened!

---

About the E-Conference:

The 8th ESH TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease.

New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

To read the scientific programme, click here!

To meet the faculty, click here!

For more information, click here!

 

---

CONFERENCE MAIN TOPICS:

• Disease Biology: The Genomics and its Consequences in MDS
• Disease Biology: Immune and Microenvironment Alterations and its Implications in MDS
• The Future of MDS Research
• When is MDS Really MDS, and When is it Really Bad MDS? Diagnosis and Prognosis
• Special Groups in MDS
• Treatment of MDS
• Current Progress in the Treatment of MDS
• Clinical trials in Europe and USA MDS consortium
• Late-Breaking Top News

---

LEARNING OBJECTIVES:

Upon completion of this CME activity, participants should be able to:

• Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics,
but also through the use of new tools, mainly molecular analysis
• Improve ability to analyze prognostic factors, including new ones
(revised IPSS, molecular analysis)
• Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation
• Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials

---

The programme will include:

Plenary Sessions - Keynote Lecture - Brief Oral Communications
Poster Walks - Controversial Debates - Ample time for in-depth discussion
“Meet the Expert” sessions on specific themes - conducive to informal scientific exchange

---

TIMING OF THE SCIENTIFIC PROGRAMME:

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join both
the LIVE PROGRAMME: April 7-10, 2022
and the PROGRAMME ON-DEMAND: March 29 - May 10, 2022

---

With the support of*:

 

Emerald E-Conference Partner
******

*ESH conference programs are developed in strict scientific independence
with no input from corporate sponsors.